Thirteen of 60 pancreatic ductal adenocarcinomas (21.7%) and two of 34 intraductal papillary mucinous neoplasms (IPMNs) (5.9%) had methylated SOCS-1. This evidence concerns the gene SOCS1 and pancreatic intraductal papillary-mucinous neoplasm.